Poster at ASH on ROR inhibitors


ASH's (The American Society of Hematology) Program Committee has selected the following manuscript for poster presentation at the ASH annual meeting 5-8 December 2015 in Orlando: "First-in-Class ROR1 Small Molecule Inhibitor (KAN0439834) Downregulated Wnt-Canonical and Non-Canonical Signaling Pathways and Induced Apoptosis of CLL Cells"

The abstract of the poster will be be published online in the December 3 supplemental volume of Blood.

The work is part of the cooperation between Kancera's research group in Solna and Håkan Mellstedts research group at Cancer Center Karolinska (CCK). The poster will be presented by Dr. Hojjat-Farsangi at CCK.

Copyright 2010 KANCERA AB, KAROLINSKA INSTITUTET SCIENCE PARK, BANVAKTSVÄGEN 22, 171 48 SOLNA. TEL: +46 (0)850 12 60 80 Website policy